By Elise Franco Herald-Journal DUNCAN, S.C. — The Sialmas family is opening its arms, and it's kitchen, to the Upstate on New Year's Day. From 6 to 11 a.m. on Monday, Melissa and Christos Sialmas and their staff at Sialmas Family Restaurant will treat all emergency medical, safety and law enforcement personnel from Spartanburg and Greenville counties to free breakfast during the restaurant's ...
from EMS via xlomafota13 on Inoreader http://ift.tt/2q6iyVx
via IFTTT
Κυριακή 31 Δεκεμβρίου 2017
SC restaurant offers free breakfast to first responders on New Year's Day
Σάββατο 30 Δεκεμβρίου 2017
Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: a French randomised double-blind phase III trial (PRODIGE 50-ASPIK)
Oxaliplatin-based adjuvant chemotherapy is standard of care for radically resected stage III colon cancer and an accepted option for high-risk stage II. Two recent retrospective studies strongly suggested that low-dose aspirin used (100 mg/d) after surgical resection of colorectal cancer with a PIK3CA mutation could act as a targeted therapy with a major protective effect on the risk of recurrence.We propose a double-blind randomized phase III study to evaluate aspirin (100 mg/d during 3 years or until recurrence) versus placebo.
from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2Cr7Hbd
via IFTTT
ACCURACY OF FECAL CALPROTECTIN FOR THE PREDICTION OF ENDOSCOPIC ACTIVITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Fecal calprotectin is a noninvasive marker of inflammatory bowel disease.
from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2DD3AIr
via IFTTT
Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: a French randomised double-blind phase III trial (PRODIGE 50-ASPIK)
Oxaliplatin-based adjuvant chemotherapy is standard of care for radically resected stage III colon cancer and an accepted option for high-risk stage II. Two recent retrospective studies strongly suggested that low-dose aspirin used (100 mg/d) after surgical resection of colorectal cancer with a PIK3CA mutation could act as a targeted therapy with a major protective effect on the risk of recurrence.We propose a double-blind randomized phase III study to evaluate aspirin (100 mg/d during 3 years or until recurrence) versus placebo.
from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2Cr7Hbd
via IFTTT
ACCURACY OF FECAL CALPROTECTIN FOR THE PREDICTION OF ENDOSCOPIC ACTIVITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Fecal calprotectin is a noninvasive marker of inflammatory bowel disease.
from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2DD3AIr
via IFTTT
Εγγραφή σε:
Αναρτήσεις (Atom)